NasdaqGS:XEL
NasdaqGS:XELElectric Utilities

Examining Xcel Energy’s Valuation After Stock Jumps 32% on Clean Power Momentum

If you follow utility stocks, you’ve probably noticed Xcel Energy popping up on more watchlists lately. Whether you’re already holding shares or thinking about jumping in, the recent moves in Xcel’s stock price have been hard to ignore. Over the last month, the stock has surged 12.0%, and it’s up a whopping 32.0% for the past year. Year-to-date performance sits at 22.3%, which is notable, especially for a company that traditionally flies a little under the radar. Some of this momentum seems...
NYSE:CLVT
NYSE:CLVTProfessional Services

Clarivate Shares Plunge 29% in 2025 Is the Market Missing Something?

If you own Clarivate or are considering a move, you are probably wondering this: does the market know something you don’t, or is the stock simply misunderstood? Clarivate’s share price has seen quite a tumble lately, sliding 1.9% in the last 7 days and 12.2% over the past month. In fact, stepping back further reveals an even steeper drop. The stock is down nearly 29% year-to-date and a staggering 87.8% over five years. That kind of performance has reset expectations and, for some, dialed up...
NYSE:PFGC
NYSE:PFGCConsumer Retailing

How the Sysco Lawsuit Settlement Shapes Performance Food Group’s Current Stock Value

If you are sizing up what to do with shares of Performance Food Group, you are definitely not alone. With the stock closing recently at $103.54 and a notable 185.5% gain over the last five years, it has drawn significant attention from investors looking for consistent growth. The last month saw a slight 0.5% dip, but that's barely a blip compared to the company's 24.6% gain over the past year and a solid 23.2% surge since the start of this year. Even in the past week, the stock posted a 3.2%...
NasdaqGS:PCRX
NasdaqGS:PCRXPharmaceuticals

A Fresh Look at Pacira BioSciences (PCRX) Valuation Following Recent Share Price Volatility

Pacira BioSciences (PCRX) has recently seen some movement in its stock price, which is sparking renewed curiosity among investors. Many are taking a closer look at the company’s overall performance and longer-term outlook. See our latest analysis for Pacira BioSciences. Pacira BioSciences' share price has experienced significant volatility recently, with a strong year-to-date price return of nearly 28% despite a challenging past month, and a notable 41% total shareholder return over the last...
NYSE:YUMC
NYSE:YUMCHospitality

Yum China (NYSE:YUMC) Valuation: Is the Recent Share Price Recovery Signaling New Upside?

Yum China Holdings (NYSE:YUMC) shares have edged higher recently, even as investors have weighed the company’s performance against ongoing market shifts. The stock’s steady move comes amid changing consumer trends and broader sector developments. See our latest analysis for Yum China Holdings. Over the past year, Yum China Holdings has seen its share price swing, with recent gains helping it claw back some losses seen earlier in 2024. While the 1-year total shareholder return remains slightly...
NasdaqGS:MDGL
NasdaqGS:MDGLBiotechs

A Fresh Look at Madrigal Pharmaceuticals (MDGL) Valuation as Rezdiffra Demand Fuels Revenue Growth and Analyst Optimism

Madrigal Pharmaceuticals (MDGL) is drawing fresh interest after reporting strong demand for its lead drug, Rezdiffra, which treats metabolic dysfunction-associated steatohepatitis, or MASH. Investors are taking note of the company’s revenue momentum and rapid expansion. See our latest analysis for Madrigal Pharmaceuticals. Madrigal’s recent run of successes, including rapid revenue gains and new talent hires, seems to be energizing the stock. The share price has climbed steadily this year,...
NYSE:PARR
NYSE:PARROil and Gas

Assessing Par Pacific’s Value After 112% Rally and Latest Industry Momentum in 2025

If you’ve been following Par Pacific Holdings lately, you might be wondering whether it’s time to jump in, hold tight, or take some gains off the table. Watching the stock price surge over 112.8% year-to-date, with a jaw-dropping 414.6% climb in the past five years, it’s hard not to be impressed by the momentum. Even after a dip of 4.1% this past week, Par Pacific is still up more than 6% over the last month and has doubled in value in just a year. These eye-popping returns are not just...